|
|
|
|
LEADER |
02213nam a2200277 u 4500 |
001 |
EB002002089 |
003 |
EBX01000000000000001164990 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Ip, Stanley
|
245 |
0 |
0 |
|a Comparative effectiveness of management strategies for gastroesophageal reflux disease
|h Elektronische Ressource
|c prepared for, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by, Tufts-New England Medical Center EPC ; investigators, Stanley Ip [and 8 others]
|
260 |
|
|
|a Rockville, Md.
|b Agency for Healthcare Research and Quality
|c 2005, [2005]
|
300 |
|
|
|a 1 PDF file (vii, 100 pages)
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Comparative Effectiveness Research
|
653 |
|
|
|a Chronic Disease / prevention & control
|
653 |
|
|
|a Gastroesophageal Reflux / therapy
|
710 |
2 |
|
|a Tufts-New England Medical Center
|b Evidence-based Practice Center
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Comparative effectiveness review
|
500 |
|
|
|a Title from PDF title page. - "December 2005.". - "Contract No. 290-02-0022."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK42949
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This report examines alternatives for managing the chronic symptoms of uncomplicated gastroesophageal reflux disease (GERD) in patients who may require long-term treatment. It summarizes the available evidence comparing the efficacy and safety of medical, surgical, and endoscopic interventions in the treatment of chronic GERD, particularly after long-term followup. Questions addressed in this report are: 1) What is the evidence of the comparative effectiveness of medical, surgical, and endoscopic treatments for improving objective and subjective outcomes in patients with chronic GERD? 2) Is there evidence that effectiveness of medical, surgical, and endoscopic treatments varies for specific patient subgroups? 3) What are the short- and long-term adverse effects associated with specific medical, surgical, and endoscopic therapies for GERD?
|